Some people lose weight slower than others after workouts, and a Kobe University...
The possibility of hydrogen-powered flight means greater opportunities for fossi...
Los Angeles, CA (July 10, 2024)— The surprising discovery of a new species of ex...
Antibiotic-drug conjugates (ADCs) are a highly competitive biologics segment. Th...
Beacon Therapeutics has secured $170 million in Series B funding, which the gene...
Susvimo was halted by Roche in mid-2022 due to manufacturing issues that prompte...
The globally recognized allogeneic cellular therapy developer, Mesoblast Limited...
The Association of the British Pharmaceutical Industry (ABPI) also called out No...
China's NMPA approved Antengene’s new indication of XPOVIO for adults with relap...
iOnctura will evaluate roginolisib in combination with GSK’s Jemperli in a Phase...
iTeos will receive $35m from GSK as the first patient is dosed in the Phase III ...
The Susvimo eye implant is filled with Lucentis, which delivers the therapy cont...
SciRhom has secured €63m ($70m) in a Series A funding round to develop iRhom2-ta...
Taiho has exercised an option for an exclusive licence for Arcus Biosciences’ qu...
Ligand Pharmaceuticals has announced a definitive agreement for the acquisition ...
Moderna and Mitsubishi Tanabe have entered into a collaboration to jointly promo...
